Developing a drug to starve cancer cells
The first experimental drug to be produced by MD Anderson’s drug discovery and development institute will kill cancer cells in a new way — by depriving them of the fuel necessary for growth and survival.
Named after MD Anderson’s Institute for Applied Cancer Science (IACS) where it was developed, IACS-10759 blocks the conversion of nutrients into the energy that fuels cancer cells. The drug does this by blocking the function of...
